2013
DOI: 10.1186/1749-8090-8-199
|View full text |Cite
|
Sign up to set email alerts
|

The eNOS 894G/T gene polymorphism and its influence on early and long-term mortality after on-pump cardiac surgery

Abstract: BackgroundThe eNOS 894G/T polymorphism (GG, GT, and TT) is associated with cardiovascular mortality and may influence cardiovascular diseases as a genetic risk factor. Moreover, this polymorphism has an impact on intraoperative hemodynamics during cardiac surgery with cardiopulmonary bypass (CPB). In this study, we analyzed the influence of this gene polymorphism on early clinical outcome in patients who underwent cardiac surgery with CPB. Also, we performed a 5-year follow-up, assessing the impact of this pol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0
2

Year Published

2015
2015
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 28 publications
0
5
0
2
Order By: Relevance
“…A recent study demonstrated a similarly significant association between the T allele genotype and prevalence of non-ischemic dilated cardiomyopathy [33]. In contrast to these results, a long-term follow-up of patients after cardiac surgery did not show increased risk for mortality in subjects who were homozygous T-allele carriers [48]. Moreover, several reports, including ours on this cohort of HF patients, have previously demonstrated a significant correlation between the G allele of the eNOS G894GT polymorphism and the presence of atrial fibrillation in systolic HF populations, which may indicate a more progressive disease [34][35][36][37].…”
Section: Discussionmentioning
confidence: 88%
“…A recent study demonstrated a similarly significant association between the T allele genotype and prevalence of non-ischemic dilated cardiomyopathy [33]. In contrast to these results, a long-term follow-up of patients after cardiac surgery did not show increased risk for mortality in subjects who were homozygous T-allele carriers [48]. Moreover, several reports, including ours on this cohort of HF patients, have previously demonstrated a significant correlation between the G allele of the eNOS G894GT polymorphism and the presence of atrial fibrillation in systolic HF populations, which may indicate a more progressive disease [34][35][36][37].…”
Section: Discussionmentioning
confidence: 88%
“…In our investigation, analysis of the distribution of the G and T alleles of the G894T eNOS polymorphism in the case and control groups showed no significant difference. A study carried out by Hinz et al (2013) that evaluated the influence of G894T polymorphism in the early clinical evolution of patients submitted to cardiac surgery found no significant difference between case and control groups. Regarding hypertension and G894T polymorphism, Niu et al (2011) analyzed 19,284 patients in the case group and 26,003 in the control group.…”
Section: Discussionmentioning
confidence: 96%
“…The five-year follow-up demonstrated no significant differences in the mortality rates between the groups. Based on the obtained results the authors concluded that this polymorphism can not be used as a marker to identify high risk groups in heterogeneous patient population undergoing a cardiac surgery with CPB [42]. A summary of all genes described in this review is presented in Table. Concluding the results of the literature search, we found that there was a very limited number of articles describing non-infectious SIRS in patients undergoing a cardiovascular surgery, including CABG, who are carriers of different alleles in genes involved in the inflammatory response [31][32][33][34][35][36][37][38][39][40].…”
Section: Introductionmentioning
confidence: 98%
“…J. Hinz et al (2013) [42] analyzed the influence of the eNOS 894G/T gene variable site polymorphism on early clinical outcome in patients who underwent cardiac surgery with CPB. 500 Caucasian patients were enrolled in the study.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation